{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:38:45Z","timestamp":1791506325369,"version":"4.3.4"},"reference-count":34,"publisher":"BMJ","issue":"11","license":[{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004243","name":"Prinses Beatrix Spierfonds","doi-asserted-by":"publisher","award":["W.OR19-24"],"award-info":[{"award-number":["W.OR19-24"]}],"id":[{"id":"10.13039\/501100004243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"accepted":{"date-parts":[[2025,4,16]]},"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Several prognostic models predict clinical outcomes in Guillain-Barr\u00e9 syndrome (GBS). Recently, neurofilament light chain (NfL) has emerged as a prognostic biomarker. We investigated the added prognostic value of NfL in serum (sNfL) and cerebrospinal fluid (cNfL) to models based on clinical factors predicting respiratory failure and inability to walk in GBS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We included patients from a randomised placebo-controlled trial (second intravenous immunoglobulin dose in GBS). Serum was acquired at entry and week 1, 2, 4 and 12 and cerebrospinal fluid at entry. NfL levels were determined on a single molecule array. The additional prognostic value of NfL to the (modified) Erasmus GBS Outcome Score ((m)EGOS) and (modified) Erasmus GBS Respiratory Insufficiency Score was evaluated using logistic regression analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In total, 293 patients were included (74 (25%) mechanically ventilated, 38\/275 (13%) unable to walk at 26 weeks). Higher sNfL at entry, week 1 and week 2 and cNfL at entry were associated with inability to walk at 4 and 26 weeks. Neither sNfL nor cNfL levels at entry were associated with respiratory failure. The EGOS and mEGOS improved after adding NfL (\u2206C-statistic range: 0.01\u20130.11), especially the models predicting outcome at 26 weeks. A new model predicting inability to walk at 26 weeks consisting of sNfL at entry, GBS disability score at entry and Medical Research Council sum score at week 2 performed best (C-statistic: 0.88 (95% CI 0.83 to 0.94)).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Addition of NfL may improve clinical prognostic models for the prediction of inability to walk, but not of respiratory failure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>NTR2224\/NL2107.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jnnp-2025-336046","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T13:20:45Z","timestamp":1746192045000},"page":"1099-1108","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["Neurofilament light chain improves clinical prognostic models for Guillain-Barr\u00e9 syndrome"],"prefix":"10.1136","volume":"96","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5584-2457","authenticated-orcid":false,"given":"Robin C M","family":"Thomma","sequence":"first","affiliation":[{"name":"Department of Neurology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands"},{"name":"Department of Immunology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda W G","family":"Luijten","sequence":"additional","affiliation":[{"name":"Department of Neurology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sander J","family":"van Tilburg","sequence":"additional","affiliation":[{"name":"Department of Immunology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1768-7550","authenticated-orcid":false,"given":"Eveline J A","family":"Wiegers","sequence":"additional","affiliation":[{"name":"Department of Neurology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte E","family":"Teunissen","sequence":"additional","affiliation":[{"name":"Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience, Amsterdam University Medical Centres, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Vermunt","sequence":"additional","affiliation":[{"name":"Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience, Amsterdam University Medical Centres, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter A","family":"van Doorn","sequence":"additional","affiliation":[{"name":"Department of Neurology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9563-4860","authenticated-orcid":false,"given":"Ruth","family":"Huizinga","sequence":"additional","affiliation":[{"name":"Department of Immunology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8985-2458","authenticated-orcid":false,"given":"Bart C","family":"Jacobs","sequence":"additional","affiliation":[{"name":"Department of Neurology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands"},{"name":"Department of Immunology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,5,2]]},"reference":[{"key":"2026081401350746000_96.11.1099.1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41572-024-00580-4","article-title":"Guillain-Barr\u00e9 syndrome","volume":"10","author":"Leonhard","year":"2024","journal-title":"Nat Rev Dis Primers"},{"key":"2026081401350746000_96.11.1099.2","doi-asserted-by":"publisher","DOI":"10.5694\/mja17.00552"},{"key":"2026081401350746000_96.11.1099.3","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(07)70130-8"},{"key":"2026081401350746000_96.11.1099.4","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182104407"},{"key":"2026081401350746000_96.11.1099.5","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21976"},{"key":"2026081401350746000_96.11.1099.6","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2022-329937"},{"key":"2026081401350746000_96.11.1099.7","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16073"},{"key":"2026081401350746000_96.11.1099.8","doi-asserted-by":"publisher","DOI":"10.1007\/s12028-023-01707-3"},{"key":"2026081401350746000_96.11.1099.9","first-page":"e518","article-title":"Predicting Outcome in Guillain-Barr\u00e9 Syndrome: International Validation of the Modified Erasmus GBS Outcome Score","volume":"98","author":"Doets","year":"2022","journal-title":"Neurology (ECronicon)"},{"key":"2026081401350746000_96.11.1099.10","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/acn3.51627","article-title":"Validation and adjustment of modified Erasmus GBS outcome score in Bangladesh","volume":"9","author":"Papri","year":"2022","journal-title":"Ann Clin Transl Neurol"},{"key":"2026081401350746000_96.11.1099.11","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26312"},{"key":"2026081401350746000_96.11.1099.12","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2023.2273386"},{"key":"2026081401350746000_96.11.1099.13","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-024-00955-x"},{"key":"2026081401350746000_96.11.1099.14","doi-asserted-by":"publisher","DOI":"10.1111\/jns.12279"},{"key":"2026081401350746000_96.11.1099.15","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-020-01737-0","article-title":"Increased serum neurofilament light chain concentration indicates poor outcome in Guillain-Barr\u00e9 syndrome","volume":"17","author":"Altmann","year":"2020","journal-title":"J Neuroinflammation"},{"key":"2026081401350746000_96.11.1099.16","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2020-323899"},{"key":"2026081401350746000_96.11.1099.17","doi-asserted-by":"publisher","DOI":"10.1111\/ene.15428"},{"key":"2026081401350746000_96.11.1099.18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105072","article-title":"Dynamics and prognostic value of serum neurofilament light chain in Guillain-Barr\u00e9 syndrome","volume":"102","author":"van Tilburg","year":"2024","journal-title":"EBioMedicine"},{"key":"2026081401350746000_96.11.1099.19","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-024-12679-5"},{"key":"2026081401350746000_96.11.1099.20","doi-asserted-by":"publisher","DOI":"10.1111\/ane.12927"},{"key":"2026081401350746000_96.11.1099.21","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.972367","article-title":"Cerebrospinal fluid neurofilament light chain predicts short-term prognosis in pediatric Guillain-Barr\u00e9 syndrome","volume":"13","author":"Jin","year":"2022","journal-title":"Front Neurol"},{"key":"2026081401350746000_96.11.1099.22","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30494-4"},{"key":"2026081401350746000_96.11.1099.23","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1002\/acn3.51676","article-title":"Age- and disease-specific reference values for neurofilament light presented in an online interactive support interface","volume":"9","author":"Vermunt","year":"2022","journal-title":"Ann Clin Transl Neurol"},{"key":"2026081401350746000_96.11.1099.24","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4"},{"key":"2026081401350746000_96.11.1099.25","doi-asserted-by":"publisher","DOI":"10.1016\/s1474-4422(22)00218-6"},{"key":"2026081401350746000_96.11.1099.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2024.108131"},{"key":"2026081401350746000_96.11.1099.27","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2004.051136"},{"key":"2026081401350746000_96.11.1099.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.neumar.2024.100003"},{"key":"2026081401350746000_96.11.1099.29","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2004.051136"},{"key":"2026081401350746000_96.11.1099.30","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(06)70603-2"},{"key":"2026081401350746000_96.11.1099.31","doi-asserted-by":"publisher","DOI":"10.1111\/jns.12234"},{"key":"2026081401350746000_96.11.1099.32","doi-asserted-by":"crossref","DOI":"10.1186\/cc10005","article-title":"Manual muscle strength testing of critically ill patients: feasibility and interobserver agreement","volume":"15","author":"Hough","year":"2011","journal-title":"Crit Care"},{"key":"2026081401350746000_96.11.1099.33","doi-asserted-by":"publisher","DOI":"10.1002\/mus.22219"},{"key":"2026081401350746000_96.11.1099.34","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awad234"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2025-336046","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T08:35:26Z","timestamp":1786696526000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2025-336046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,2]]},"references-count":34,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,10,15]]},"published-print":{"date-parts":[[2025,11]]}},"alternative-id":["10.1136\/jnnp-2025-336046"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2025-336046","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,2]]}}}